Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
October 2008
Features
Cover Story
Medical Management of Parkinson’s Disease
A comprehensive discussion of the causes, epidemiology, diagnosis, symptoms, and pharmacotherapy for this movement disorder is presented, with an emphasis on the efficacy and adverse effects of pharmaceutical treatments.
Marvin M. Goldenberg, PhD, RPh, MS
Health Care and Law
Why Is Health Care Regulation So Complex?
Although the intricacies of health care regulation may seem inefficient and unwieldy, our system of local, state, and national checks and balances actually makes a certain amount of sense. Dr. Field discusses the logic behind the complexities of the present regulatory system.
Robert I. Field, JD, MPH, PhD
Commentary
The Next President’s Prescription for Action on Drugs
Obama and McCain Positions Similar — with One Major Difference
The outlook for Medicare Part D and universal health insurance coverage may depend, in part, on who is elected President and how Congress decides to act.
Stephen Barlas
P&T Snapshot
Trends in Managing Multiple Sclerosis
The Multiple Sclerosis Trend Report reveals the need for many improvements in treating this expensive and complex disease, such as containing costs of biotech drugs, easing the process of obtaining patient reimbursements and physician payments, developing a role for specialty pharmacy, and eliminating barriers to patient–pharmacy communication.
Mari Edlin and Peter Sonnenreich, MA
Departments
Editorial
The Jefferson School of Health Policy and Population Health
David Nash, MD, MBA, talks about a new school of health policy to open next year at Thomas Jefferson University.
David B. Nash, MD, MBA
Medication Errors
Misprogram a PCA Pump? It’s Easy!
Matthew Grissinger, RPh, FASCP, explains how easy it is to misprogram pumps used for patient-controlled analgesia.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Congress Agrees on the Need for Comparativeness Research
Stephen Barlas discusses the need for Congress to fund a program to evaluate the cost effectiveness of drugs and medical devices.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From Altace to Zyprexa, P&T presents the latest studies and information about FDA approvals, new indications, product recalls, and industry updates.
Drug Forecast
Alvimopan (Entereg), a Peripherally Acting mu-Opioid Receptor Antagonist For Postoperative Ileus
Dr. Erowele reviews alvimopan, a mu-opioid receptor antagonist (Entereg), for postoperative ileus.
Goldina Ikezuagu Erowele, PharmD
